Cyrielle Elyette Fougeroux

Cyrielle Elyette Fougeroux

Postdoc

ORCID: 0000-0002-7566-8377

Publication year:
All
1 - 2 out of 2Page size: 10
  1. 2023
  2. Published

    Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved Neisseria gonorrhoeae SliC antigen that blocks human lysozyme

    Martinez, Fabian Guadalupe, Zielke, R. A., Fougeroux, Cyrielle Elyette, Li, L., Sander, Adam F. & Sikora, A. E., 2023, In: Infection and Immunity. 91, 12, 21 p., e00245-23.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    First-in-human use of a modular capsid virus-like vaccine platform: An open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

    Smit, M. J., Sander, A. F., Ariaans, M. B. P. A., Fougeroux, C., Heinzel, C., Fendel, R., Esen, M., Kremsner, P. G., Ter Heine, R., Wertheim, H. F., Idorn, M., Paludan, S. R., Underwood, A. P., Binderup, A., Ramirez, S., Bukh, J., Soegaard, M., Erdogan, S. M., Gustavsson, T., Clemmensen, S. & 14 others, Theander, Thor Grundtvig, Salanti, Ali, Hamborg, M., de Jongh, W. A., McCall, M. B. B., Nielsen, Morten Agertoug, Mordmüller, B. G., COUGH-1 trial study group, C. T. S. G., Dagil, Robert, Goksøyr, L., Hulen, T. M., Brygger, C. M. J., Khalifé, P. K. & Vidal-Calvo, E. E., 2023, In: The Lancet Microbe. 4, 3, p. e140-e148

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 96680075